LDL-C Targets in Secondary Prevention: How Low Should We Go?
<h3>Abstract</h3><p dir="ltr">The benefits of lowering low-density lipoprotein cholesterol (LDL-C), mainly using high-intensity statin therapy, and its impact on decreasing the recurrence of atherosclerotic cardiovascular disease (ASCVD) in secondary prevention has been w...
Saved in:
| Main Author: | Karim Bayoumy (3496688) (author) |
|---|---|
| Other Authors: | Mohammed Gaber (14151942) (author), Preethi Mani (14151945) (author), Rishi Puri (6090599) (author), Eoin Donnellan (12122073) (author), Leslie Cho (8859803) (author), Donald Clark (14151948) (author), Seth S. Martin (8164878) (author), Mohamed B. Elshazly (14151951) (author) |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
by: Nagham N. Hindi (18526815)
Published: (2021) -
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
by: Amina Kamar (295977)
Published: (2021) -
The role of protective genetic variants in modulating epigenetic aging
by: Yosra Bejaoui (8552574)
Published: (2025) -
The new accounting standard IFRS 9 and its impact on how banks should provision for credit losses
by: ALBANNA, AMNA AHMAD
Published: (2019) -
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
by: Elysia M Alvarez (12229352)
Published: (2022)